Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOTILDE: Cyclosporine in AMI with Cardiogenic Shock
NCT01901471Phase 2Withdrawn
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2015
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and cardiogenic shock comparing CsA Group with Placebo group (2 arms). Primary endpoint: Sequential Organ Failure Assessment at 24 hours. Planned start Sep 2015; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
myocardial infarction (MI)cardiogenic shock
Beyond the preview
Go deeper on NCT01901471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901471.